Disconnecting multicellular networks in brain tumours

V Venkataramani, M Schneider, FA Giordano… - Nature Reviews …, 2022 - nature.com
Cancer cells can organize and communicate in functional networks. Similarly to other
networks in biology and sociology, these can be highly relevant for growth and resilience. In …

Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities

DD Shi, JA Guo, HI Hoffman, J Su… - The Lancet …, 2022 - thelancet.com
With increasing attention on the essential roles of the tumour microenvironment in recent
years, the nervous system has emerged as a novel and crucial facilitator of cancer growth. In …

Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma

VM Ravi, P Will, J Kueckelhaus, N Sun, K Joseph… - Cancer cell, 2022 - cell.com
Glioblastomas are malignant tumors of the central nervous system hallmarked by subclonal
diversity and dynamic adaptation amid developmental hierarchies. The source of dynamic …

Insights and opportunities at the crossroads of cancer and neuroscience

C Pan, F Winkler - Nature cell biology, 2022 - nature.com
The biological and pathological importance of mutual interactions between the nervous
system and cancer have become increasingly evident. The emerging field of cancer …

PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma

S Heuer, I Burghaus, M Gose, T Kessler, F Sahm… - BMC cancer, 2024 - Springer
Background Glioblastoma is the most frequent and a particularly malignant primary brain
tumor with no efficacy-proven standard therapy for recurrence. It has recently been …

[HTML][HTML] Brain tumor networks in diffuse glioma

Y Yang, MC Schubert, T Kuner, W Wick, F Winkler… - …, 2022 - Elsevier
Diffuse gliomas are primary brain tumors associated with a poor prognosis. Cellular and
molecular mechanisms driving the invasive growth patterns and therapeutic resistance are …

Therapeutic targeting of glioblastoma and the interactions with its microenvironment

V Genoud, B Kinnersley, NF Brown, D Ottaviani… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma (GBM) is the most aggressive brain tumour. Patients with
GBM have a dismal survival and there is a distinct lack of curative treatments. We are …

Neural signaling in cancer

MB Keough, M Monje - Annual review of neuroscience, 2022 - annualreviews.org
Nervous system activity regulates development, homeostasis, and plasticity of the brain as
well as other organs in the body. These mechanisms are subverted in cancer to propel …

From laboratory studies to clinical trials: temozolomide use in IDH-mutant gliomas

X Sun, S Turcan - Cells, 2021 - mdpi.com
In this review, we discuss the use of the alkylating agent temozolomide (TMZ) in the
treatment of IDH-mutant gliomas. We describe the challenges associated with TMZ in clinical …

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial

T Zeyen, AL Potthoff, R Nemeth, DH Heiland… - Trials, 2022 - Springer
Background Glioblastoma is the most frequent and malignant primary brain tumor. Even in
the subgroup with O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation …